Ozempic, a brand name for semaglutide, has gained significant attention in the medical community and among patients for its ...

The effects that a pause may have on your body may depend on why you're taking the medication in the first place.

NVO’s success in the past few years is underscored by its marketed semaglutide (GLP-1 agonist) medicines. Wegovy is a ...

The decision will largely prevent compounding pharmacies from making and selling compounded versions of the drug in the next ...

Authorized generics are the exact copies of branded drugs, sold by another company with the branded drug manufacturer’s ...

The US Food and Drug Administration on Monday approved a generic version of the daily injectable GLP-1 medicine liraglutide ...

Semaglutide, the active ingredient in Ozempic and Wegovy, has been linked to a condition that can cause permanent vision loss ...

Tirzepatide, the active ingredient in both Mounjaro for type 2 diabetes and Zepbound for weight loss, was in short supply for ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

WVE-007 is a novel approach for treating obesity and is designed to silence INHBE to achieve healthy, sustainable weight loss through fat ...

Financial analyst assesses the credit market concerns and declining operating results for WW International, with insight on ...

Novo Nordisk’s latest attempt in weight loss, a combination drug called CagriSema, matched the bar set by Lilly’s currently ...